Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigious | ||
Readability |
H.S. sophomore Good
|
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.1 EX-10.1 Standard Exclusive License Agreement
- 10.2 EX-10.2 Proposal Between Registrant and Patheon Pharmaceuticals, Inc.
- 10.3 EX-10.3 Form of Nonstatutory Stock Option Agreement
- 10.4 EX-10.4 Incentive Stock Option Agreement (Paul Rubin)
- 10.5 EX-10.5 Incentive Stock Option Agreement (Trevor Philips)
- 10.6 EX-10.6 Incentive Stock Option Agreement (Walter Newman)
- 10.7 EX-10.7 Incentive Stock Option Agreement (Frederick Finnegan)
- 10.8 EX-10.8 Incentive Stock Option Agreement (Frank Thomas)
- 31.1 EX-31.1 Section 302 Certification of CEO
- 31.2 EX-31.2 Section 302 Certification of CFO
- 32.1 EX-32.1 Section 906 Certification of CEO
- 32.2 EX-32.2 Section 906 Certification of CFO
Related press release
CRTX similar filings
External links